Pharma Capital
Market: ASX
52-week High/Low: A$0.68 / A$0.30
Sector: Pharma & Biotech
Market Cap: A$64.45M

Paradigm Biopharmaceuticals (ASX:PAR) is listed on the Australian Securities Exchange.


Paradigm Biopharmaceuticals

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.